Sunshine Biopharma Inc
-0.0349 (-3.07%)
Upgrade to Real-Time
Regular Market
Volume 3,592
Bid Price 1.12
Ask Price 1.16
News -
Day High 1.14


52 Week Range


Day Low 1.1001
Company Name Stock Ticker Symbol Market Type
Sunshine Biopharma Inc SBFM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0349 -3.07% 1.1001 09:40:08
Open Price Low Price High Price Close Price Prev Close
1.14 1.1001 1.14 1.135
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
21 3,592 $ 1.14 $ 4,083 - 0.62 - 9.87
Last Trade Time Type Quantity Stock Price Currency
09:38:25 2 $ 1.12 USD


Draw Mode:

Sunshine Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.85M 22.59M 22.23M $ 228.43k $ - -4.65 1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 30.00k 0.80%

more financials information »

Sunshine Biopharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SBFM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.281.301.081.22277,320-0.1799-14.05%
1 Month0.79651.300.75011.05371,4010.303638.12%
3 Months0.94881.300.620.8930842370,1780.151315.95%
6 Months1.331.500.620.9968055435,317-0.2299-17.29%
1 Year2.759.870.624.853,430,858-1.65-60.0%
3 Years2.759.870.624.853,430,858-1.65-60.0%
5 Years2.759.870.624.853,430,858-1.65-60.0%

Sunshine Biopharma Description

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).